Tag: Protecting Consumers, Taxpayers, and the Economy

Merkley, Wyden Join Effort to Restore the Chevron Doctrine Following MAGA Supreme Court Ruling

Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden joined the recently introduced Stop Corporate Capture Act after the Supreme Court—stacked with Trump-appointed justices—overturned the 40-year-old Chevron doctrine. The bill codifies Chevron deference and strengthens the rulemaking process to block corporations from hijacking our government.  “This MAGA Supreme

Wyden, Merkley, Colleagues Call on Postal Service to Prepare for Upcoming Election

Washington, D.C. — U.S. Senator Ron Wyden said today he is leading Senate colleagues including U.S. Senator Jeff Merkley in calling on Postmaster General DeJoy and the U.S. Postal Service to share their plans to accommodate high volumes of mail expected in the upcoming 2024 general election in Oregon and nationwide. “In 2020, the

Senator Merkley Drills Down on Big Oil Lies in Budget Committee Hearing

Senator Merkley asks Representative Raskin about Big Oil’s efforts to avoid accountability for its role in climate chaos in a Senate Budget Committee Hearing titled, “Denial, Disinformation, and Doublespeak: Big Oil’s Evolving Efforts to Avoid, Accountability for Climate Change” on May 1, 2024. Watch the full hearing: https://www.budget.senate.gov/hearings/denial-disinformation-and-doublespeak_big-oils-evolving-efforts-to-avoid-accountability-for-climate-change

Merkley Statement on Cannabis Rescheduling

Merkley: “Cannabis has not been descheduled, so we still have work to do.” Washington, D.C. – Following the Biden administration’s cannabis rescheduling announcement, Oregon’s U.S. Senator Jeff Merkley—a lead sponsor of the SAFER Banking Act—shared the following statement: “I pushed the Biden administration to make good on the President’s commitment

Warren, Sanders, Merkley Slam Chamber of Commerce for Opposition to Biden Administration’s Proposal to Boost Competition, Lower Drug Prices

“These efforts are a mistake, and are not consistent with the Chamber’s stated goal of ‘expand(ing) access to and improv(ing) the affordability of high-quality health care services for all Americans.’ If successful, they will undermine the Biden Administration’s effort to reduce drug prices and insurance premiums, hurting consumers and small and large businesses.” 

en_USEnglish